Evidence map›Paper›PMID 36830564›Full record

ReviewBiomolecules2023

Targeting Apoptotic Pathway of Cancer Cells with Phytochemicals and Plant-Based Nanomaterials.

Atif Khurshid Wani, Nahid Akhtar, Tahir Ul Gani Mir, Rattandeep Singh, Prakash Kumar Jha, Shyam Kumar Mallik, Shruti Sinha, Surya Kant Tripathi, Abha Jain, Aprajita Jha and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 125 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Evaluation of the Anticancer Effects ofInternational journal of molecular sciences · 2026
    Article
  14. Fortified Chestnut Honey Triggers Apoptosis in Colon Cancer Cells.Plant foods for human nutrition (Dordrecht, Netherlands) · 2026
    Article
  15. Article
  16. Special Issue "Anticancer Drug Discovery Based on Natural Products".International journal of molecular sciences · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Atif Khurshid WaniSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India.ORCID 0000-0002-8820-1231
Nahid AkhtarSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India.ORCID 0000-0002-8286-3736
Tahir Ul Gani MirSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India.ORCID 0000-0001-9579-4410
Rattandeep SinghSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India.
Prakash Kumar JhaFeed the Future Innovation Lab for Collaborative Research on Sustainable Intensification, Kansas State University, Manhattan, KS 66506, USA.ORCID 0000-0001-5973-711X
Shyam Kumar MallikCollege of Medical and Allied Sciences, Purbanchal University, Morang 56600, Nepal.
Shruti SinhaUNC Blood Research Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Surya Kant TripathiLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0002-9633-4405
Abha JainDivision of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Aprajita JhaSchool of Biotechnology, Kalinga Institute of Industrial Technology, Bhubaneswar 751024, India.ORCID 0000-0003-2009-8829
Hari Prasad DevkotaGraduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.ORCID 0000-0002-0509-1621
Ajit PrakashDepartment of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC 27599, USA.ORCID 0000-0001-7628-0457
Lovely Professional University · INUniversity of North Carolina at Chapel Hill · USKansas State University · USKIIT University · INPokhara University · NPPurbanchal University · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apoptosis is the elimination of functionally non-essential, neoplastic, and infected cells via the mitochondrial pathway or death receptor pathway. The process of apoptosis is highly regulated through membrane channels and apoptogenic proteins. Apoptosis maintains cellular balance within the human body through cell cycle progression. Loss of apoptosis control prolongs cancer cell survival and allows the accumulation of mutations that can promote angiogenesis, promote cell proliferation, disrupt differentiation, and increase invasiveness during tumor progression. The apoptotic pathway has been extensively studied as a potential drug target in cancer treatment. However, the off-target activities of drugs and negative implications have been a matter of concern over the years. Phytochemicals (PCs) have been studied for their efficacy in various cancer cell lines individually and synergistically. The development of nanoparticles (NPs) through green synthesis has added a new dimension to the advancement of plant-based nanomaterials for effective cancer treatment. This review provides a detailed insight into the fundamental molecular pathways of programmed cell death and highlights the role of PCs along with the existing drugs and plant-based NPs in treating cancer by targeting its programmed cell death (PCD) network.

Indexed as

NanostructuresNeoplasmsApoptosisHumansMitochondriaPhytochemicalsPlantsPhytochemicalsapoptosiscancerdrugsinhibitorsnanomaterialsphytochemicals

Identifiers

PMID36830564
PMCPMC9953589
OpenAlexW4317425373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.